-
cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales
Thursday, August 15, 2024 - 2:51pm | 493Read More...cbdMD, Inc. (NYSE:YCBD), an operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs announced its financial results on Wednesday for the third quarter of fiscal 2024 ending June 30, 2024. Year-over-year, operational losses improved markedly,...
-
cbdMD Reports YoY Dip In Q1 Net Sales, Shrinks Operating Loss, Expands Into Hemp And Mushroom Products Markets
Wednesday, February 14, 2024 - 11:03am | 561Read More...cbdMD, Inc. (NYSE:YCBD) announced its first quarter financial results Tuesday for the three months ended Dec. 31, 2023. The North Carolina-based medical cannabis company said that it has improved its operating loss from $4.1 in the first quarter of 2023 to $1.1 million for the first quarter of...
-
Medical Cannabis Pioneer cbdMD Secures $1.2M To Fund Rollout Of Functional Mushroom Products
Monday, February 5, 2024 - 10:06am | 546Read More...Medical marijuana producer cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBD) said Friday that it had entered into a securities purchase agreement with five institutional investors to secure financing for the national rollout of its new ATRx Labs functional mushroom products. The company will use the proceeds for...
